Fasting Glucose
For informational purposes only — not medical advice. Always consult a qualified healthcare provider before making changes to your health regimen. Full disclaimer →
- The 'normal' fasting glucose range extends to 99 mg/dL, but the longevity-optimal range is substantially lower — 70–85 mg/dL. Multiple large prospective cohort studies have found that fasting glucose in the high-normal range (90–99 mg/dL) is associated with significantly higher cardiovascular mortality and incident diabetes compared to values in the low-normal range. The diagnostic cutoffs were designed to identify disease, not to mark the boundary of optimal health.
- Fasting glucose is a late marker — it rises after insulin resistance has already been present for years. The typical sequence of metabolic decline runs: insulin resistance → compensatory hyperinsulinemia (elevated fasting insulin with normal glucose) → eventual glucose elevation as beta cell compensation fails. Fasting glucose doesn't meaningfully rise until the pancreas can no longer compensate. By the time fasting glucose reaches 100 mg/dL, insulin resistance has typically been present for a decade or more. Fasting insulin is an earlier signal.
- Variability in fasting glucose is clinically important and often overlooked. Fasting glucose is affected by sleep quality (even a single night of poor sleep raises fasting glucose), psychological stress (cortisol raises hepatic glucose output), the timing and composition of the last meal before fasting began, and physical activity the previous day. A single elevated reading may not reflect chronic metabolic status; trends across multiple measurements under consistent conditions are more informative than any one value.
- Fasting glucose above 100 mg/dL (prediabetes) predicts a 50% risk of developing type 2 diabetes within 10 years — but is nearly fully reversible with lifestyle intervention. Unlike many cardiovascular risk factors, prediabetes is highly responsive to dietary modification, increased physical activity, and weight loss. The DPP (Diabetes Prevention Program) showed that intensive lifestyle intervention reduced progression from prediabetes to diabetes by 58% — more effectively than metformin. The earlier the intervention, the more complete the reversal.
- Fasting glucose must be interpreted alongside fasting insulin, HbA1c, and in some cases C-peptide to understand the full metabolic picture. Fasting glucose measures one point in the metabolic cascade. Fasting insulin reveals the compensatory effort being made to maintain that glucose level. HbA1c reflects the 90-day average. C-peptide captures pancreatic output directly. These markers together describe where someone is on the metabolic health spectrum in a way that no single marker can alone.
The Most Ordered Test — and the Most Misinterpreted
Fasting glucose is the most commonly ordered metabolic test in medicine. It is included in every CMP, every BMP, and virtually every standard annual blood panel. Most people have had dozens of fasting glucose measurements by middle age.
And yet it is systematically misinterpreted in clinical practice — not because the test is flawed, but because the reference ranges it's compared against were calibrated for disease detection, not longevity optimization.
The standard clinical framework divides fasting glucose into three buckets: normal (< 100 mg/dL), prediabetes (100–125 mg/dL), and diabetes (≥ 126 mg/dL). A patient at 99 mg/dL is told their glucose is normal. A patient at 100 mg/dL is told they have prediabetes. The clinical response — often zero for the former and lifestyle counseling for the latter — treats a 1 mg/dL difference as a categorical threshold.
The biology does not work this way. Cardiovascular risk, all-cause mortality, and biological aging measures show a continuous relationship with fasting glucose that extends well below 100 mg/dL. The Whitehall II cohort, which followed over 10,000 British civil servants for decades, found that fasting glucose in the 90–99 mg/dL range — fully "normal" by clinical standards — was associated with significantly higher rates of type 2 diabetes, cardiovascular events, and dementia compared to values in the 70–85 mg/dL range. 1
Fasting Glucose in the Metabolic Cascade
Understanding what fasting glucose tells you — and doesn't — requires understanding where it sits in the sequence of metabolic decline.
Insulin resistance typically develops over years before fasting glucose rises. The pancreas compensates by secreting more insulin to maintain glucose in the normal range. Fasting glucose can remain perfectly normal while fasting insulin is two, three, or four times the optimal level — the pancreas working overtime to produce the appearance of metabolic health.
Fasting glucose only rises when pancreatic compensation starts to fail. At that point, the condition has typically been present for a decade or more. The prediabetes diagnosis — triggered at 100 mg/dL — is not catching the problem early. It is catching the late stage of a long process.
This is why fasting insulin is the earlier signal, and why fasting glucose must always be interpreted in combination with it.
| Fasting Glucose | Clinical Category | Longevity Interpretation |
|---|---|---|
| 70–85 mg/dL | Normal | Longevity optimal — lowest population risk |
| 86–99 mg/dL | Normal | High-normal — investigate fasting insulin |
| 100–125 mg/dL | Prediabetes | Significant metabolic dysfunction — highly reversible |
| ≥ 126 mg/dL | Diabetes threshold | Clinical diagnosis; requires medical management |
| Range Type | Value (mg/dL) | Notes |
|---|---|---|
| Standard Clinical Range | Normal: < 100 mg/dL · Prediabetes: 100–125 mg/dL · Diabetes: ≥ 126 mg/dL | Designed to identify disease risk — not longevity optimisation. |
| Longevity-Optimal Target | 70–85 mg/dL |
Associated with reduced all-cause mortality and extended healthspan.
The longevity-optimal range of 70–85 mg/dL reflects where population studies show the lowest cardiovascular and all-cause mortality risk. Values in the 86–99 mg/dL range are technically normal but represent a gradient of increasing metabolic stress that becomes clinically meaningful at the population level. A single fasting glucose value should always be interpreted alongside fasting insulin and HbA1c for context — a person with fasting glucose of 95 mg/dL and fasting insulin of 15 µIU/mL has a very different metabolic picture than someone with fasting glucose of 95 mg/dL and fasting insulin of 4 µIU/mL. Fasting glucose alone cannot distinguish between the two.
|
Already have your results? See what your Fasting Glucose and other markers reveal about your longevity in 60 seconds.
Analyze My Labs →Affiliate disclosure: we may earn a commission if you purchase through these links at no extra cost to you.
What is the difference between fasting glucose and HbA1c — which one should I prioritize?
They measure different things and both have a role. Fasting glucose is a snapshot — it tells you where your blood sugar is right now, on this particular morning, after this particular overnight fast. HbA1c is a 90-day average — it integrates all the blood glucose fluctuations over the past three months, including post-meal spikes that fasting glucose never captures. Fasting glucose is more sensitive to day-to-day variability (sleep, stress, recent activity), while HbA1c is more stable but responds slowly to intervention. For longevity monitoring, both matter: HbA1c identifies the post-meal glucose burden that fasting glucose misses; fasting glucose identifies acute metabolic stress and, when interpreted alongside fasting insulin, reveals the early compensatory phase of insulin resistance. People with excellent fasting glucose can have elevated HbA1c due to post-meal spikes — a pattern called 'normal fasting glucose but impaired glucose tolerance' that HbA1c captures.
My fasting glucose is 92 mg/dL — my doctor says that's normal. Should I be concerned?
A fasting glucose of 92 mg/dL is technically within the normal reference range, and your doctor is correct that it does not meet the clinical criteria for prediabetes (which begins at 100 mg/dL). From a longevity perspective, 92 mg/dL sits in the upper half of the normal range, which is associated with higher cardiovascular risk in population studies compared to values in the 70–85 mg/dL range — a gradient that clinical guidelines do not flag but that matters at the population level. Whether this is clinically meaningful for you specifically depends heavily on context: What is your fasting insulin? What is your HbA1c? What are your triglycerides? A fasting glucose of 92 with a fasting insulin of 4, HbA1c of 5.0%, and triglycerides of 65 is a very different situation than the same glucose with fasting insulin of 18, HbA1c of 5.6%, and triglycerides of 180. The glucose value alone doesn't answer the question.
How should I prepare for a fasting glucose test?
Fast for at least 8 hours before the blood draw — ideally 10–12 hours. Water is fine; coffee (even black) and other beverages should be avoided as they can affect glucose readings. Aim to draw the sample at roughly the same time of day across repeat measurements, ideally in the morning. Avoid intense exercise in the 24 hours before the test, as vigorous exercise can transiently lower fasting glucose in some people and raise it in others. Try to ensure adequate sleep the night before — sleep deprivation reliably raises fasting glucose through cortisol and sympathetic nervous system activation. Reducing stress on the morning of the draw is similarly useful, as anxiety raises cortisol, which raises hepatic glucose output.
What causes fasting glucose to be high in the morning even in people who eat well?
This is called the 'dawn phenomenon' — a physiologically normal morning rise in blood glucose driven by the circadian cortisol awakening response. Cortisol peaks in the early morning hours, stimulating the liver to release glucose in preparation for the day. In people with fully intact insulin sensitivity, this glucose is quickly cleared. In people with insulin resistance or prediabetes, the dawn glucose rise is exaggerated and clears more slowly, producing higher fasting values. Some people have a variant called the 'Somogyi effect' — nocturnal hypoglycemia followed by a compensatory glucose rebound from glucagon — though this is more relevant for people on insulin. For most adults with high-normal fasting glucose, the dawn phenomenon is the primary driver, and the degree of the rise reflects insulin sensitivity as much as diet.